Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium + Olodaterol FDC vs FC in COPD
NCT02030535Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2014
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tiotropium, olodaterol in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Jan 2014; status: completed.
02
Drugs
tiotropiumolodaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02030535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02030535.